Formulations and methods of using nitric oxide mimetics against a malignant cell phenotype
US6946484B2 · kind B2 · utility
39Cited by
10References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 26, 2001 |
| Grant date | Sep 20, 2005 |
| Priority date | — |
| Expiry date | Dec 14, 2021 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Methods and formulations for inhibiting and preventing a malignant cell phenotype by administering to cells a low dose of a nitric oxide mimetic are provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.